BELLUS Health Insiders

BLUDelisted Stock  USD 14.74  0.00  0.00%   
BELLUS Health employs about 74 people. The company is managed by 28 executives with a total tenure of roughly 258 years, averaging almost 9.0 years of service per executive, having 2.64 employees per reported executive. Breaking down BELLUS Health's management performance can provide insight into the firm performance.
Mark Levy  CEO
Joint CEO, Executive Director
Brett Levy  CEO
Joint CEO, Executive Director
  
Check out Trending Equities to better understand how to build diversified portfolios. Also, note that the market value of any company could be tightly coupled with the direction of predictive economic indicators such as signals in bureau of economic analysis.

BELLUS Health Management Team Effectiveness

The company has Return on Asset of (0.167) % which means that on every $100 spent on assets, it lost $0.167. This is way below average. In the same way, it shows a return on shareholders' equity (ROE) of (0.2676) %, meaning that it generated no profit with money invested by stockholders. BELLUS Health's management efficiency ratios could be used to measure how well BELLUS Health manages its routine affairs as well as how well it operates its assets and liabilities.

BELLUS Health Workforce Comparison

BELLUS Health is number one stock in number of employees category among related companies. The total workforce of Health Care industry is currently estimated at about 3,948. BELLUS Health claims roughly 74.0 in number of employees contributing just under 2% to equities under Health Care industry.

BELLUS Health Notable Stakeholders

A BELLUS Health stakeholder refers to an individual interested in an outcome of the business. Different stakeholders have different interests, and companies such as BELLUS Health often face trade-offs trying to please all of them. BELLUS Health's stakeholders can have a positive or negative influence on the entity's direction, and there are a lot of executives involved in getting BELLUS Health's stock to the level that pleases all shareholders. Keeping track of the stakeholders is a great way to stay on top of things affecting its ongoing price.
Mark LevyJoint CEO, Executive DirectorProfile
Brett LevyJoint CEO, Executive DirectorProfile
Laurence NestadtIndependent Non-Executive Chairman of the BoardProfile
Tong TeoNon-Executive Chairman of the Board, Non-Executive Independent DirectorProfile
Kantilal ChampaklalCFOProfile
Mahtani BhagwandasIndependent Non-Executive DirectorProfile
Jerry VilakaziNon-Executive Independent DirectorProfile
Dean SuntupFinancial Director, DirectorProfile
Joe MthimunyeIndependent Non-Executive DirectorProfile
Kevin EllerineNon-Executive DirectorProfile
Peter MoeIndependent Non-Executive DirectorProfile
Lik GohIndependent Non-Executive DirectorProfile
Phuti MahanyeleNon-Executive Independent DirectorProfile
Gary HarlowIndependent Non-Executive DirectorProfile
Yusuf MahomedIndependent Non-Executive DirectorProfile
Sebastien RoyCo SecProfile
Janine EdenGroup Company SecretaryProfile
Denis GarceauChief OfficerProfile
FFPM MBBChChief OfficerProfile
Peck PengFinancial ControllerProfile
Ramzi BenamarChief OfficerProfile
Tony MatzouranisSr DevelProfile
Chee KwanGeneral Manager - Property DivisionProfile
Siok LimGeneral Manager of Region Suppliers Pte Ltd.Profile
Cheng TanCompany SecretaryProfile
Roberto BelliniCEO PresProfile
Daniel MatthewsDirector CommunicationsProfile
Catherine MDChief OfficerProfile

About BELLUS Health Management Performance

The success or failure of an entity such as BELLUS Health often depends on how effective the management is. BELLUS Health management team is responsible for propelling the future growth in the right direction and administering and controlling the business activities and accounting for the results. Ineffective management usually contributes to failure in the company's future performance for all stakeholders equally, but most importantly, for investors. So it is important to measure the effectiveness of BELLUS management before purchasing its stock. In many ways, it's all about finding the answer to one important question - Are they doing the right thing right now? How would we assess whether the BELLUS management is utilizing all available resources in the best possible way? Also, how well is the company doing relative to others in its sector and the market as a whole? The answer can be found by analyzing a few important fundamental indicators such as return on assets and return on equity.
BELLUS Health Inc., a clinical stage biopharmaceutical company, develops therapeutics for the treatment of refractory chronic cough and other cough hypersensitivity indications. The company was incorporated in 1993 and is based in Laval, Canada. Bellus Health operates under Biotechnology classification in the United States and is traded on NASDAQ Exchange. It employs 40 people.
The data published in BELLUS Health's official financial statements usually reflect BELLUS Health's business processes, product offerings, services, and other fundamental events. But there are other numbers, ratios, or fundamental indicators derived from these statements that are easier to understand and visualize within the underlying realities that drive quantitative information of BELLUS Health. For example, before you start analyzing numbers published by BELLUS accountants, it's critical to develop an understanding of what BELLUS Health's liquidity, profitability, and earnings quality are in the context of the Biotechnology space in which it operates.
Please note, the presentation of BELLUS Health's financial position, as portrayed in its financial statements, is often influenced by management's estimates, judgments, and sometimes even manipulations. In the best case, BELLUS Health's management is honest, while the outside auditors are strict and uncompromising. Whatever the case, the imprecision that can be found in BELLUS Health's accounting process means that the reasonable investor should take a skeptical approach toward the financial statement analysis of BELLUS Health. Please utilize our Beneish M Score to check the likelihood of BELLUS Health's management manipulating its earnings.

BELLUS Health Workforce Analysis

Traditionally, organizations such as BELLUS Health use manpower efficiency calculations for various incentive schemes, employee appraisal, or as an initiative to improve the processes. However, it can also be used by investors to make long-term investment decisions. The trends in the profit per employee or revenue per employee are measured by net income or revenue divided by the current number of full-time employees over a given time interval. Because workforce needs differ across sectors, these ratios could be used to compare BELLUS Health within its industry.

BELLUS Health Manpower Efficiency

Return on BELLUS Health Manpower

Revenue Per Employee216
Revenue Per Executive571
Net Loss Per Employee1M
Net Loss Per Executive2.7M
Working Capital Per Employee4.6M
Working Capital Per Executive12.1M
Check out Trending Equities to better understand how to build diversified portfolios. Also, note that the market value of any company could be tightly coupled with the direction of predictive economic indicators such as signals in bureau of economic analysis.
You can also try the Portfolio Optimization module to compute new portfolio that will generate highest expected return given your specified tolerance for risk.

Other Consideration for investing in BELLUS Stock

If you are still planning to invest in BELLUS Health check if it may still be traded through OTC markets such as Pink Sheets or OTC Bulletin Board. You may also purchase it directly from the company, but this is not always possible and may require contacting the company directly. Please note that delisted stocks are often considered to be more risky investments, as they are no longer subject to the same regulatory and reporting requirements as listed stocks. Therefore, it is essential to carefully research the BELLUS Health's history and understand the potential risks before investing.
Companies Directory
Evaluate performance of over 100,000 Stocks, Funds, and ETFs against different fundamentals
Portfolio Analyzer
Portfolio analysis module that provides access to portfolio diagnostics and optimization engine
Efficient Frontier
Plot and analyze your portfolio and positions against risk-return landscape of the market.
Idea Breakdown
Analyze constituents of all Macroaxis ideas. Macroaxis investment ideas are predefined, sector-focused investing themes
AI Investment Finder
Use AI to screen and filter profitable investment opportunities
Portfolio Anywhere
Track or share privately all of your investments from the convenience of any device
Funds Screener
Find actively-traded funds from around the world traded on over 30 global exchanges
Equity Analysis
Research over 250,000 global equities including funds, stocks and ETFs to find investment opportunities
Cryptocurrency Center
Build and monitor diversified portfolio of extremely risky digital assets and cryptocurrency